---
author: Harvey Guo
created: 2024-03-15 15:31
modified: 2024-03-15 15:31
aliases:
  - Benzodiazepines
share: true
---
![[../../assets/img/Pasted image 20240315154449.png|Pasted image 20240315154449.png]]
# Benzodiazepines
## Agents
- Short-acting (half-life 1–12 hours): <font color="#ffc000">T</font>riazolam, <font color="#ffc000">O</font>xazepam, and <font color="#ffc000">M</font>idazolam
- Intermediate-acting (half-life 12–40 hours): <font color="#ffc000">lor</font>azepam, <font color="#ffc000">c</font>lonazepam, <font color="#ffc000">a</font>lprazolam, <font color="#ffc000">t</font>emazepam
- Long-acting (half-life > 40 hours): <font color="#ffc000">diaz</font>epam, chlor<font color="#ffc000">diaz</font><font color="#ffc000"></font>epoxide, 
>[!Mnemonic] 
>- All contain AZE from Benzodi<font color="#ffc000">aze</font>pine
>- Separate short , intermediate , and long-acting benzodiazepines with the phrase:
>	- <font color="#ffc000">TOM</font> moved fast , to <font color="#ffc000">lure</font> the <font color="#ffc000">CAT</font> , but still took several <font color="#ffc000">días</font> (Spanish for days) .
## Adverse effects
### Benzodiazepine overdose
- <span style="background:rgba(240, 200, 0, 0.2)">Antidote: flumazenil</span>
	- Mechanism of action: competitive antagonism at GABA receptor

>[!Mnemonic] 
>Flum-<font color="#ffc000">AZE</font>-<font color="#ffc000">NIL</font> = turns benzos into nothing
# Barbiturates
---
| Feature             | Barbiturates                                                     | Benzodiazepines                                                |
|---------------------|------------------------------------------------------------------|----------------------------------------------------------------|
| Mechanism of Action | Act on GABA<sub>A</sub> receptors, enhancing GABA activity       | Act on GABA<sub>A</sub> receptors, enhancing GABA activity     |
| Potency             | Generally more potent                                            | Generally less potent                                          |
| Safety Profile      | Higher risk of overdose and addiction                            | Lower risk of overdose and addiction                           |
| Sedative Effect     | Strong sedative effects                                          | Moderate sedative effects                                      |
| Duration of Action  | Short to long duration depending on the type                     | Short to intermediate duration                                 |
| Metabolism          | Metabolized by liver enzymes                                     | Metabolized by liver enzymes                                   |
| Indications         | Historically used as sedatives, <span style="background:rgba(240, 200, 0, 0.2)">anesthetics</span>, and anticonvulsants | Primarily used as anxiolytics, sedatives, and muscle relaxants |
| Withdrawal          | Severe withdrawal symptoms, including seizures                   | Generally milder withdrawal symptoms                           |
| Risk of Dependence  | High risk of physical and psychological dependence               | Lower risk of physical and psychological dependence            |
| Examples            | Phenobarbital, Pentobarbital, Secobarbital, <span style="background:rgba(240, 200, 0, 0.2)">Primidone: essential tremor</span>                       | Diazepam, Alprazolam, Lorazepam, Clonazepam                    |

# Nonbenzodiazepine hypnotics (Z-drugs)
---
## Agents 
- <span style="background:rgba(240, 200, 0, 0.2)">Zolpidem</span> (imidazopyridine): half-life ∼ 2 hours
	- Brand name: <span style="background:rgba(240, 200, 0, 0.2)">Stilnox</span>
- Zaleplon (pyrazolopyrimidine): half-life ∼ 1 hour
- Eszopiclone: half-life ∼ 6 hours
## Mechanism of action 
- <span style="background:rgba(240, 200, 0, 0.2)">Similar to benzodiazepines</span>
- Selectivity for GABAA receptors with α1 subunits (corresponding to the BZ1 subtype)
- Short-acting due to fast metabolization by liver enzymes